Key result
Youth athletes with anxiety or depression had significantly higher odds of experiencing chest pain or dyspnea during exercise compared to those without these conditions (aOR 1.92).
Why the study?
Mental health conditions are common among youth athletes, but limited information exists on how these disorders impact their overall health and athletic performance.
Do mental health disorders and their pharmacological treatments affect cardiovascular symptoms and ECG abnormalities in youth athletes?
Cross-Sectional (n=7,425)
Yes
Do mental health disorders and their pharmacological treatments affect cardiovascular symptoms and ECG abnormalities in youth athletes?
Pharmacological treatment of anxiety and depression in youth athletes may reduce exercise-induced cardiovascular symptoms such as chest pain and dyspnea, potentially encouraging sports participation.
Background There is a high rate of mental health conditions among the youth athlete population; however, there is limited information about the impact mental health disorders can have on their overall health and athletic performance. Methods Data was collected by Simon’s Heart, a nonprofit organization that coordinates pre-participation examinations (PPE) for adolescents. Multivariable logistic regression adjusting for age, gender, race, BMI, asthma, anemia, and participation in sports was performed to assess the relationship between mental health disorders and each outcome. Results The HeartBytes dataset is composed of screening data from 7425 patients ranging from 12 to 20 years old. We identified 565 patients (7.6%) diagnosed with ADHD and 370 patients (5.0%) diagnosed with anxiety/depression. Screened participants without a diagnosis of ADHD, anxiety, or depression were significantly more likely to play sports compared to those with these conditions (75.4% vs 59.4%, P < 0.001 for ADHD; 89.4% vs 72.4%, P < 0.001 for anxiety/depression). Those with anxiety/depression not on an antidepressant (OR: 2.09, CI: 1.31–3.19, P < 0.01), but not those on an antidepressant (OR: 1.87, CI: 0.96–3.33, P = 0.05), were more likely to report chest pain or dyspnea with exercise. Those with ADHD not on a stimulant (aOR 1.91, CI 1.22–2.89, p < 0.01), but not those on a stimulant (aOR 1.40, CI 0.82–2.24, p = 0.19) were more likely to report palpitations. ECG abnormalities were not more prevalent regardless of anxiety/depression, ADHD, or medical therapy with an antidepressant or a stimulant. Conclusion Young athletes with anxiety/depression were less likely to participate in sports than healthy individuals. This may be due to deterrence as a result of the symptoms, such as dyspnea or chest pain, they experience during exercise. However, those taking antidepressants had fewer symptoms during exercise. Given that exercise has been shown to improve depression/anxiety, increasing the rate of antidepressant use may lead to less symptoms, more exercise, and an overall improvement in the mental health conditions in this population.
No takes yet. Share an insight, caveat, or question.
Vyas et al. (2023) conducted a cross-sectional in Youth athletes (n=7,425). Anxiety or depression vs. No anxiety or depression was evaluated on Chest pain or dyspnea with exercise (aOR 1.92, 95% CI 1.30-2.77, p=<0.001). Youth athletes with anxiety or depression had significantly higher odds of experiencing chest pain or dyspnea during exercise compared to those without these conditions (aOR 1.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: